Drugs / Captafer®
last change Aug 2017 re-read 2 minutes ago

Captafer®

Developed for
inflammatory bowel disease · iron deficiency anemia
Investigated by
American University of Beirut Medical Center

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02774057 Mar 2016 → Jul 2017 inflammatory bowel disease, iron deficiency anemia American University of Beirut Medical Center Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Captafer ClinicalTrials.gov intervention name — accepted as the source's own label NCT02774057
Route Oral “Captafer is a new iron-free oral preparation” NCT02774057